Dr Luca Toschi, formerly a member of PRECISION ONCOLOGY CONNECT and now a leading member of LUNG CONNECT, developed this resource with COR2ED.
Dr Luca Toschi, formerly a member of PRECISION ONCOLOGY CONNECT and now a leading member of LUNG CONNECT, developed this resource with COR2ED.
AstraZeneca, BMS, Boehringer, Ingelheim, Lilly, MSD, Pfizer and Roche.
Exploring the impact of molecular subtypes
Expert insights on systemic, loco-regional, and multimodal therapies
Two emerging and two established targets
Announcing the publication of survey results
An expert overview of the EMERALD subgroup analysis
Managing patients with nccRCC: guidelines, recommendations, and best practice